EX-FILING FEES

Exhibit 107

CALCULATION OF FILING FEE TABLE

Registration Statement on Form F-3

(Form Type)

Connect Biopharma Holdings Limited

(Exact Name of Registrant as Specified in its Charter)

Table 1 – Newly Registered and Carry Forward Securities



	Security Type	Security Class Title	Fee Calculation or Carry Forward Rule	Amount Registered	Proposed Maximum Offering Price Per Unit	Maximum Aggregate Offering Price	Fee Rate	Amount of Registration Fee	Carry Forward Form Type	Carry Forward File Number	Carry Forward Initial Effective Date	Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward

Newly Registered Securities

Fees To Be Paid	Equity	Ordinary shares, $0.000174 par value per share ⁽¹⁾	—	—	—	—	—	—

Fees To Be Paid	Equity	Preferred Shares, $0.000174 par value per share	—	—	—	—	—	—

Fees To Be Paid	Debt	Debt Securities	—	—	—	—	—	—

Fees To Be Paid	Other	Warrants	—	—	—	—	—	—

Fees To Be Paid	Other	Purchase Contracts	—	—	—	—	—	—

Fees To Be Paid	Other	Units	—	—	—	—	—	—

Fees To Be Paid	Unallocated (Universal Shelf)	₍₂₎	457(o)	$300,000,000⁽³⁾	N/A	$0⁽³⁾⁽⁴⁾	0.00015310	$0

Fees Previously Paid	N/A	N/A	N/A	—	—	—	—	—

Carry Forward Securities

Carry Forward Securities	Equity	Ordinary shares, $0.000174 par value per share ⁽¹⁾	415(a)(6)	$300,000,000⁽⁴⁾		$300,000,000 ⁽⁴⁾			Form F-3	333-264340	07/06/2022	$27,810.00

	Total Offering Amounts					$300,000,000⁽⁴⁾		$27,810.00

	Total Fees Previously Paid							—

	Total Fee Offsets							—

	Net Fee Due							$0

(1)

These ordinary shares will be represented by American Depositary Shares, or ADSs, each of which represents one ordinary share of the registrant. ADSs issuable on deposit of the ordinary shares registered hereby have been registered pursuant to a separate registration statement on Form F-6 (File No. 333-254215). Includes rights to acquire Ordinary Shares of the Company under any shareholder rights plan then in effect, if applicable under the terms of any such plan.

(2)

An unspecified number of securities or aggregate principal amount, as applicable, is being registered as may from time to time be offered at unspecified prices and, in addition, an unspecified number of additional Ordinary Shares is being registered as may be issued from time to time upon conversion of any Debt Securities that are convertible into Ordinary Shares or pursuant to any anti-dilution adjustments with respect to any such convertible Debt Securities.

(3)

Estimated solely for the purpose of calculating the registration fee. No separate consideration will be received for Ordinary Shares that are issued upon conversion of Debt Securities or upon exercise of Warrants registered hereunder. The aggregate maximum offering price of all securities issued by the Company pursuant to this registration statement will not exceed $300,000,000.

(4)

The registrant previously paid registration fees in the aggregate of $27,810 with respect to a Registration Statement on Form F-3, as amended (File No. 333-264340) (the “Prior Registration Statement”). Pursuant to Rule 415(a)(6) (“Rule 415(a)(6)”) promulgated under the Securities Act of 1933, as amended (the “Securities Act”), the securities registered pursuant to this Registration Statement on Form F-3 (this “Registration Statement”) include $300,000,000 of securities previously registered on the Prior Registration Statement which remain unsold (the “Unsold Securities”). Pursuant to Rule 415(a)(6), the registration fee of $27,810 associated with the offering of the Unsold Securities (based on the filing fee rate in effect at the time of the filing of the Prior Registration Statement) is hereby carried forward to be applied to the Unsold Securities registered hereunder, and no additional filing fee is due with respect to the Unsold Securities in connection with the filing of this Registration Statement. Pursuant to Rule 415(a)(6), the offering of the Unsold Securities under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this Registration Statement.